Global Aptamers Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global aptamers market in its upcoming report titled, “Global Aptamers Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global aptamers market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global aptamers market report has been segmented on the basis of type, application, end user, and region.

Aptamers are short stranded oligonucleotides that binds to specific target molecules with high affinity. Aptamers can discriminate specific target site with high precision. It provides various advantages which includes high temperature stability, cost effective production and hence widely used in diagnostic, therapeutic, biomarker discovery, drug discovery. Aptamers are of different types having similar properties but are distinctly unique. Furthermore, aptamers can successfully identified as binding molecules for whole cells, viruses and tissues.

Rising investment in research and development by pharmaceutical and biopharmaceutical companies for development of novel aptamers is expected to fuel the growth of global aptamers market over the forecast period. Continuous development for high-quality aptamers by manufacturers and growing use of aptamers in drug discovery and disease treatment is expected to boost the growth of global aptamers market over the forecast period.

Stringent regulations related the use of aptamer is major factor restraining the growth of aptamers market over the forecast period.

However, technological advancements and innovations focusing on development of aptamers with high efficiency and low cost is expected to create new opportunities for existing as well as new market entrant in the global aptamers market over the forecast period.

North America market dominates the global aptamers market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of dominant players in the market and well developed healthcare infrastructure, technological advancements in the region and. Europe accounts for second-largest revenue share contribution to the global aptamers market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Europe is projected to register comparatively faster growth in terms of revenue over the next 10 years owing increasing number of research institutes coupled with rising R&D activities in the region.

Global aptamers market segmentation;

By type:

• Nucleic Acid Aptamers
  • DNA-Based Aptamers
  • RNA-Based Aptamers
  • XNA-Based Aptamers
• Peptide Aptamers

 By application:

• Diagnostics
• Therapeutics
• Research and Development

By end user:

• Biotechnology and Pharmaceutical Industry
• Contract Research Organization
• Academic and Research Institutions

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa